Iol Chemcials And Pharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd, commonly referred to as IOL Chemicals, is a prominent player in the Indian pharmaceutical and chemical industry. Headquartered in Punjab, India, the company has established a significant presence in various operational regions, focusing on the production of high-quality active pharmaceutical ingredients (APIs) and specialty chemicals. Founded in 1986, IOL Chemicals has achieved key milestones, including expansions in manufacturing capabilities and product diversification. The company is renowned for its core offerings, which include APIs for analgesics, anti-inflammatory, and anti-diabetic medications, as well as a range of specialty chemicals. IOL Chemicals distinguishes itself through its commitment to quality and innovation, positioning itself as a trusted supplier in both domestic and international markets. With a strong market presence, IOL Chemicals continues to contribute to the pharmaceutical landscape, reflecting its dedication to excellence and sustainability.
DitchCarbon Score
How does Iol Chemcials And Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Iol Chemcials And Pharmaceuticals's score of 56 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Iol Chemcials And Pharmaceuticals's reported carbon emissions
In 2024, IOL Chemicals and Pharmaceuticals reported total carbon emissions of approximately 175,343,000 kg CO2e. This figure includes 49,521,000 kg CO2e from Scope 1 emissions, 6,179,000 kg CO2e from Scope 2 emissions, and a significant 119,643,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by 2050. In the near term, IOL Chemicals and Pharmaceuticals plans to reduce absolute Scope 1 and 2 emissions by 58.8% by FY2033, using FY2022 as the baseline. Additionally, they aim to cut Scope 3 emissions by 35% within the same timeframe. For the long term, the company targets a 90% reduction in both Scope 1 and 2 emissions, as well as Scope 3 emissions, by 2050. These targets align with the Science Based Targets initiative (SBTi) and reflect the company's commitment to sustainable practices within the pharmaceuticals sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 24,928,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 1,171,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 779,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Iol Chemcials And Pharmaceuticals is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
